START will leverage Trialing’s platform to distribute curated information on ongoing early-phase oncology trials.

MVID has a lethal natural history requiring life-sustaining parenteral support (PS), which includes total parenteral ...

GEN announces approval in the Netherlands to initiate patient enrollment in April 2026 for the Phase II Proof of ...

Stem cells are gaining attention for their potential to treat leukemia, certain solid tumor cancers, and inherited metabolic ...

AI Conductor operates as an orchestration layer across PhaseV’s vertical AI platform.

In a phase 2b clinical trial, an investigational oral therapy called PrimeC was found to be safe and well tolerated in people ...

"This is changing the way we practice prostate cancer." ...

PhaseWell Research ("PhaseWell"), a multisite clinical research company, today announced the strategic acquisition of Chase ...

For patients facing a multiple myeloma diagnosis, the journey is often defined by a search for the next line of defense. For survivor Julie Cohen, that search led her to the front lines of medical ...

Research found just 4% of trials over the past decade allowed the inclusion of pregnant women.

Residual gastric volume precluded endoscopic examination ...

LAKE ZURICH, IL, UNITED STATES, March 17, 2026 /EINPresswire.com/ -- The Sikh community in the United States, estimated ...